Ursprung des Netzwerks ersten Grades von Sanjeev Pathak
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 32 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sanjeev Pathak
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Chief Operating Officer Chief Operating Officer Corporate Officer/Principal | |
| BELLICUM PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance Baker Bros. Advisors LP (BBA) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Julian Baker and Felix Baker in 2000 and do-business-as Baker Brothers Investments. BBA serves as a discretionary investment advisor to pooled investment vehicles operating as private investment funds and to a managed account. | Investment Managers | Founder Portfolio Manager-Equities | |
| MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Investor Relations Contact | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Secretary | |
| HERON THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| HOLOGIC, INC. | Medical Specialties | Public Communications Contact | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of British Columbia | College/University | Undergraduate Degree | |
| Simon Fraser University | College/University | Undergraduate Degree | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| OTONOMY | Biotechnology | Chief Tech/Sci/R&D Officer | |
Tioga Pharmaceuticals, Inc.
 Tioga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tioga Pharmaceuticals, Inc. manufactures pharmaceutical products. It develops therapies for the treatment of pruritus. The company was founded by Stuart J. Collinson in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Locanabio, Inc.
 Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Packaged Software | Chief Tech/Sci/R&D Officer | |
DTx Pharma, Inc.
 DTx Pharma, Inc. Pharmaceuticals: MajorHealth Technology DTx Pharma, Inc. engages in the provision of biotechnology solutions. It focuses on the utilization of fatty acids to enable the delivery of RNA therapeutics to tissues and organ systems beyond the liver. The company was founded by Arthur T. Suckow, John Grundy, and Adam Pavlicek in August 2017 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Francis Cauffman, Inc.
 Francis Cauffman, Inc. Engineering & ConstructionIndustrial Services Francis Cauffman, Inc. provides architecture, interior design, and planning services. The firm specializes in healthcare, science & technology and corporate. The company was founded by Hughes D. Cauffman, James Francis and George Wikinson in 1954 and is headquartered in New York, NY. | Engineering & Construction | Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Chairman | |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Medical Specialties | Investor Relations Contact | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| State University of New York at Buffalo | College/University | Masters Business Admin | |
Amgen Ventures LLC
 Amgen Ventures LLC Investment ManagersFinance Amgen Ventures LLC (Amgen Ventures) is a venture capital firm, a subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California. | Investment Managers | Corporate Officer/Principal | |
Vivelix Pharmaceuticals, Ltd.
 Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Vivelix Pharmaceuticals, Ltd. manufactures and sells pharmaceutical products. The private company is based in Hamilton, BM. and has subsidiaries in the United States. The Bermudian company was founded by William P. Forbes. | Pharmaceuticals: Major | Director/Board Member | |
| KINIKSA PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Director/Board Member | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Alberta | College/University | Doctorate Degree | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| New York University School of Law | College/University | Graduate Degree | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Stealth BioTherapeutics, Inc.
 Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Pharmaceuticals: Major | Director of Finance/CFO | |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Medical/Nursing Services | Director of Finance/CFO | |
| ALPHATEC HOLDINGS, INC. | Medical Specialties | Investor Relations Contact |
Statistik
International
| Vereinigte Staaten | 44 |
| Kanada | 4 |
| Frankreich | 2 |
| Bermuda | 2 |
| Niederlande | 2 |
Sektoral
| Health Technology | 37 |
| Consumer Services | 8 |
| Finance | 4 |
| Technology Services | 2 |
| Industrial Services | 2 |
Operativ
| Director/Board Member | 93 |
| Corporate Officer/Principal | 68 |
| Independent Dir/Board Member | 51 |
| Chief Tech/Sci/R&D Officer | 33 |
| Undergraduate Degree | 26 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Laura Brege | 27 |
| Eliseo Salinas | 22 |
| Julian Baker | 20 |
| Don Soland | 14 |
| Kimberly Manhard | 14 |
| James Daly | 13 |
| Stephen Biggar | 12 |
| Stephen Davis | 11 |
| Elizabeth Garofalo | 11 |
| Ebun Garner | 11 |
| Srdjan Stankovic | 11 |
| Elena Ridloff | 10 |
| Katherine Bishop | 10 |
| Edmund Harrigan | 10 |
| Jennifer J. Rhodes | 9 |
- Börse
- Insiders
- Sanjeev Pathak
- Unternehmensverbindungen
